Sysmex Corporation and bioMerieux Japan, Ltd. Form a Commercial Joint Venture for the Japanese In Vitro Diagnostics Market
KOBE, Japan & MARCY L'ETOILE, France--(BUSINESS WIRE)--Regulatory News: Sysmex Corporation (HQ: Kobe, Japan; President: Hisashi Ietsugu) and bioMérieux (Euronext: BIM) announce they have signed an agreement by which Sysmex will take a 34% equity stake in bioMérieux Japan, Ltd.